SlideShare a Scribd company logo
ACUTE KIDNEY INJURY
Anatomy of the Kidney
Cardiac OutputApproximately 1,200 ml of blood or 25 % of
flows through the kidney in one minute
Renal
artery and
vein
Fibrous
capsule
Corte
x
Pelvis
Pyramid (medulla)
Ureter
Deep inside the cortex and
the medulla regions are long
hairpin-like structures
called nephrons, these are
the functional urine
producing unit of the kidney
© 2012 – Michel Helmy 2
The Nephron
The urine producing part of the kidney
Distal
tubule
Collecting
duct
Loop
of
Henle
Peritubula
r
capillaries
Proximal
tubule
Bowman’
s
capsule
Glomerulu
s
Afferent
arteriole
(wider)
Efferent
arteriole(narrow
)
There are one million Nephrons in each kidney
The efferent arteriole,
which is narrower than the
afferent arteriole, creating
a hydrostatic pressure in
glomerulus
© 2012 – Michel Helmy 3
Renal Function
Secretion of three different hormones:
SECRETORY
FUNCTION
EXCRETORY
FUNCTION
Renin: regulate blood pressure
Vitamin D: regulate calcium uptake
Excretion product of the kidney: urine
EPO: regulate red blood cell production
Remove excess fluid Remove waste
products
Urea & Creatinine
Regulate acid/base balance
Regulate electrolyte levels
© 2012 – Michel Helmy 4
Definition: AKI = ARF?
AKI = Acute Kidney Injury
Intended to describe the entire
spectrum of disease from being
relatively mild to severe.
© 2012 – Michel Helmy 5
ARF = Acute Renal Failure
Defined as renal function
inadequate to clear the
waste products of
metabolism despite the
absence of correction of
hemodynamic or
mechanical causes.
Clinical manifestations of renal failure
include the following:
•Uremic symptoms (drowsiness, nausea,
hiccough, twitching)
•Hyperkalemia
•Hyponatremia
•Metabolic acidosis
Defined as an abrupt change in serum
creatinine and/or urine output and
classified according the RIFLE criteria
Definition of AKI
Acute kidney injury (AKI) is defined as any of the
following (Not Graded):
•Increase in SCr by ≥ 0.3 mg/dl (≥ 26.5 µmol/l) within 48
hours;
OR
•Increase in SCr to ≥ 1.5 times baseline, which is known
or presumed to have occurred within prior 7 days
OR
•Urine volume <0.5 ml/kg/h for 6 hours
© 2012 – Michel Helmy 6
Conclusion: AKI is not ARF
As you have seen, the terms acute kidney injury (AKI) and acute renal failure
(ARF) are not synonymous.
While the term renal failure is best reserved for patients who have lost renal
function to the point that life can no longer be sustained without
intervention, AKI is used to describe the milder as well as severe forms of
acute renal dysfunction in patients.
Let us have a deeper look at the classification of AKI…
© 2012 – Michel Helmy 7
Traditional classification of ARF
Post-renal
ARF
Intrinsic-renal
ARF
The causes of ARF are traditionally divided into three categories.
Although this division is useful for classification, all three categories may
occur simultaneously in a given patient. ARF is a complication that can occur
following any medical condition. It can result from pre-renal causes, intrinsic
renal causes or post-renal causes.
Acute Renal Failure Pre-renal ARF
© 2012 – Michel Helmy 8
Pre-renal ARF
Kidney hypoperfusion (reduced blood supply) results in
both renal ischemia (reduced supply of oxygenated
blood) and low GFR
By far the most commonly type of ARF seen in ICU
Common causes:
•intravascular volume depletion
dehydration, hemorrhage
•decreased cardiac output
congestive heart failure, infarct
•systemic vasodilatation
(dilation of blood vessels)
anaphylactic shock, sepsis
Acute Renal Failure
© 2012 – Michel Helmy 9
Intrinsic ARF
Possible causes:
•miscellaneous renal diseases
•toxins
Necrosis (is Greek for dead) = death of cell and living tissue
Tubule is part of the Nephron, the urine forming part of the
kidney
Acute Renal Failure
Intrinsic renal causes account for
35-40% of ARF cases.
The causes of intrinsic renal failure are
diseases or toxins causing
damage of the small renal vessels and
glomeruli, commonly resulting
in acute tubular necrosis.
© 2012 – Michel Helmy 10
Post-renal ARF
Increased pressure on the Bowman’s capsule offers a
resistance to normal filtration pressure, which causes an
acute reduction in GFR
Cause:
acute obstruction of the flow of
urine
Acute Renal Failure
Post-renal causes account only for about 5% of
ARF cases. They are associated with acute obstruction
of the flow of urine which can occur at any point in the
urinary tract. The obstruction creates a back flow of
urine in the kidney which
results in an increased pressure on The Bowman’s
capsule. The constant pressure offers a resistance to
the normal filtration pressure, which causes an acute
reduction in GRF.
© 2012 – Michel Helmy 11
Causes of AKI
Volume-responsive AKI
© 2012 – Michel Helmy 12
Postoperative AKIHypotension
Sepsis-induced AKI
Now let’s go back to the concept of AKI!
AKI is common in the critically ill, especially in patients with sepsis and other forms of systemic
inflammation (e.g. major surgery, trauma, burns), but other causes must be considered. Let us look
at the 4 most common causes first:
•ADQI (Acute Dialysis Quality Initiative) is a process initiated by a group of physicians
from different parts of the world, with the objective to seek consensus and evidence
and establish guidelines towards AKI.
•They have proposed the RIFLE classification as a definition of AKI. RIFLE defines three
grades of severity of ARF on the basis of either an acute increase in serum
creatinine, decrease in GFR or decreased urine output.
•Risk
•Injury
•Failure Outcome:
•Loss
•End-stage renal disease
AKI … Stages (RIFLE Criteria)
20
Classification of AKI according to RIFLE criteria
RIFLE defines three
grades of severity of AKI
on the basis of either:
•acute increase in serum
creatinine
•decrease in GFR
•decreased urine output.
Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care.
2004
Gambro Acute Therapies supports the RIFLE definition of AKI
© 2012 – Michel Helmy 21
22
Staging of AKI2.1.2:
AKI is staged for severity according to the
following criteria (below). (Not Graded)
Stage Serum Creatinine Urine Output
1 1.5-1.9 times baseline OR
≥0.3 mg/dl (≥ 26.5 µmol/l) increase
<0.5 ml/kg/h for 6-12
hours
2 2.0-2.9 times baseline <0.5 ml/kg/h for ≥12
hours
3 3.0 times baseline OR increase in serum creatinine
to ≥4.0 mg/dl (≥ 353.6 µmol/l) OR initiation of renal
replacement therapy OR, in patients <18 years,
decrease in eGFR to <35 ml/min per 1.73 m2
<0.3 ml/kg/h for ≥ 24
hours OR Anuria for ≥
12 hours
RIFLE criteria: Urine Output
• Approximately 50-60% of AKI cases are non-oliguric
• Patients may continue to make urine despite an inadequate glomerular
filtration
• Although prognosis is often better if urine output is maintained, use of diuretics
to promote urine output does not seem to improve outcome (and some studies
even suggests harm)
Anuria: <100 ml/24 hour
Oliguria: 100-400 ml/24
hour
Nonoliguria: >400 ml/24 hour
Definition
Now when do we talk of ‘Oliguria’? And when is a patient ‘non-
oliguric’?
© 2012 – Michel Helmy 16
Diagnostic work up
1. Urinalysis: Microscopic evaluation of
urinary sediment.
• Presence of few formed elements or hyaline casts is
suggestive of prerenal or postrenal azotemia.
• Many RBCs may suggest calculi , trauma , infection or
tumor
• Eosinophilia : occurs in 95 % of patients with acute
allergic nephritis
• Brownish pigmented cellular casts and many renal
epithelia cells are seen in patients with acute tubular
necrosis (ATN )
• Pigmented casts without erythrocytes in the sediment
from urine but with positive dipstick for occult blood
indicates hemoglobinuria or myoglobinuria
• Dipstick test: trace or no proteinuria with pre-renal
and post-renal AKI;
• mild to moderate proteinuria with ATN and moderate
to severe proteinuria with glomerular diseases.
• RBCs and RBC casts in glomerular diseases
• Crystals, RBCs and WBCs in post-renal ARF.
2. Urine and blood Chemistry:
• Most of these tests help to differentiate prerenal
azotemia, in which tubular reabsorption function is
preserved from acute tubular necrosis where tubular
reabsorption is severely disturbed.
Osmolality or specific gravity:
• decreased in ATN and pos-renal AKI (urine is diluted)
• while increased in pre-renal AKI ( urine is
concentrated)
• BUN/plasma creatinine ratio: the BUN/plasma
creatinine ratio is
• normal at 10-15:1 in ATN,
• but may be greater than 20:1 in prerenal disease due
to the increase in the passive reabsorption of urea that
follows the enhanced proximal transport of sodium
and water.
• Thus, a high ratio is highly suggestive of prerenal
disease as long as some other cause is not present.
But this criterion is not highly specific.
FE Na
• Fractional excretion of Na+: is ratio of urine-to-
plasma Na ratio to urine-to-plasma creatinine
expressed as a percentage
• [ (UNa/PNa)/(Ucr/Pcr )X 100].
• Value below 1% suggest prerenal failure , and values
above 1% suggest ATN
• Serum K+ and other electrolytes
3. Radiography/imaging
• Ultrasonography: helps to see the presence of two
kidneys, for evaluating kidney size and shape, and for
detecting hydronephrosis or hydroureter.
• It also helps to see renal calculi, and renal vein
thrombosis.
• Retrograde pyelography: is done when
obstructive uropathy is suspected
Management of AKI
1. Prevention:
• Because there are no specific therapies for ischemic or
nephrotoxic AKI,
Many cases of ischemic AKI can be avoided by close
attention to cardiovascular function and intravascularintravascular
volume in high-risk patientsvolume in high-risk patients, such as the elderly and
those with preexisting renal insufficiency.
• Aggressive restoration of intravascular volume has
been shown to reduce the incidence of ischemic AKI
dramatically after major surgery or trauma, burns, or
cholera prevention is of paramount importance.
• The incidence of nephrotoxic ARF can be reduced
by tailoring the dosage of potential nephrotoxins to
body size and GFR; for example, reducing the dose or
frequency of administration of drugs in patients with
preexisting renal impairment
• Maintenance of urine output: Loop diuretics may be
usefully to convert the oliguric form of ATN to the
nonoliguric form.
• High doses of loop diuretics such as Furosemide (up
to 200 to 400 mg intravenously) may promote
diuresis in patients who fail to respond to
conventional doses
Look for cause and treat
• Specific Therapies:
• To date, there are no specific therapies for established
intrinsic renal ARF due to ischemia or nephrotoxicity.
• Management of these disorders should focus on
elimination of the causative hemodynamic
abnormality or toxin, avoidance of additional
insults, and prevention and treatment of
complications.
• Specific treatment of other causes of intrinsic renal
ARF depends on the underlying pathology.
Prerenal ARF:
• The composition of replacement fluids for treatment
of prerenal ARF due to hypovolemia must be tailored
according to the composition of the lost fluid.
• Severe hypovolemia due to hemorrhage should be
corrected with packed red blood cells, whereas isotonic
saline is usually appropriate replacement for mild to
moderate hemorrhage or plasma loss (e.g., burns,
pancreatitis).
• Urinary and gastrointestinal fluids can vary greatly
in composition but are usually hypotonic.
• Hypotonic solutions (e.g., 0.45% saline) are
usually recommended as initial replacement in
patients with prerenal ARF due to increased urinary
or gastrointestinal fluid losses, although isotonic
saline may be more appropriate in severe cases
• Subsequent therapy should be based on
measurements of the volume and ionic content of
excreted or drained fluids. Serum potassium and
acid-base status should be monitored carefully.
Postrenal ARF:
• Management of postrenal ARF requires close
collaboration between nephrologist, urologist, and
radiologist.
• Obstruction of the urethra or bladder neck is usually
managed initially by transurethral or suprapubic
placement of a bladder catheter, which provides
temporary relief while the obstructing lesion, is
identified and treated definitively. Similarly, ureteric
obstruction may be treated initially by percutaneous
catheterization of the dilated renal pelvis or ureter.
4. Supportive Measures: (Conservative therapy )
• Dietary management:
• Generally, sufficient calorie reflects a diet that
provides 40-60 gm of protein and 35-50 kcal/kg lean
body weight.
• In some patients, severe catabolism occurs and
protein supplementation to achieve 1.25 gm of
protein /kg body weight is required to maintain
nitrogen balance.
• Restricting dietary protein to approximately 0.6
g/kg per day of protein of high biologic value (i.e.,
rich in essential amino acids) may be recommended
in sever azotemia.
Fluid and electrolyte management :
• Following correction of hypovolemia,
• Total oral and intravenous fluid administration should
be equal to daily sensible losses (via urine, stool, and
NG tune o surgical drainage ) plus estimated
insensible ( i.e. , respiratory and derma ) losses which
usually equals 400 – 500 ml/day.
• Strict input output monitoring is important.
• Hypervolemia: can usually be managed by
restriction of salt and water intake and diuretics.
• Metabolic acidosis: is not treated unless serum
bicarbonate concentration falls below 15 mmol/L or
arterial pH falls below 7.2.
• More severe acidosis is corrected by oral or
intravenous sodium bicarbonate.
• Initial rates of replacement are guided by estimates of
bicarbonate deficit and adjusted thereafter according
to serum levels.
• Patients are monitored for complications of
bicarbonate administration such as hypervolemia,
metabolic alkalosis, hypocalcemia, and hypokalemia.
• From a practical point of view, most patients
requiring sodium bicarbonate need emergency
dialysis within days.
Hyperkalemia: cardiac and neurologic complications
may occur if serum K+ level is > 6.5 mEq/L
• o Restrict dietary K+ intake
• o Give calcium gluconate 10 ml of 10% solution over
5
minutes
• o Glucose solution 50 ml of 50 % glucose plus
Insulin
10 units IV
• o Give potassium –binding ion exchange resin
• o Dialysis: it medial therapy fails or the patient is
very
• Hyperphosphatemia is usually controlled by
restriction of dietary phosphate and by oral aluminum
hydroxide or calcium carbonate, which reduce
gastrointestinal absorption of phosphate.
• Hypocalcemia does not usually require treatment.
• Anemia: may necessitate blood transfusion if severe
or if recovery is delayed.
• GI bleeding: Regular doses of antacids appear to
reduce the incidence of gastrointestinal hemorrhage
significantly and may be more effective in this regard
than H2 antagonists, or proton pump inhibitors.
• Meticulous care of intravenous cannulae, bladder
catheters, and other invasive devices is mandatory to
avoid infections
Dialysis
• Indications and Modalities of Dialysis: - Dialysis
replaces renal function until regeneration and repair
restore renal function. Hemodialysis and peritoneal
dialysis appear equally effective for management of
ARF. Absolute indications for dialysis include:
• 􀂾 Symptoms or signs of the uremic syndrome
• 􀂾 Refractory hypervolemia
• 􀂾 Sever hyperkalemia
• 􀂾 Metabolic acidosis.
• Patients with no complicating factors who survive an
episode of acute renal failure have a 90 % chance of
complete recovery of kidney function.
RECOVERY
Complete Renal Recovery is defined when:
Serum Creatinine (SCrt) is not more than 50% increased
from baseline
example: if baseline SCrt is 1 mg/dL (88 mmol/L)
complete recovery is said to occur if the new steady
state SCrt is <1.5 mg/dL (133 mmol/L)
Partial Renal Recovery is defined when:
The above condition for complete recovery is not met
but the patient does not require chronic dialysis (i.e.
renal ‘loss’ has not occurred)
Acute kidney injury

More Related Content

PPTX
Renovascular disorders
PPTX
Acute Kidney Injury
PPTX
Acute kidney injury
PPTX
Acute kidney injury
PPTX
Acute kidney injury defnition, causes,
PDF
Chronic Kidney Disease
PPTX
Glomerular disease
PPTX
Acute Kidney Injury (AKI)
Renovascular disorders
Acute Kidney Injury
Acute kidney injury
Acute kidney injury
Acute kidney injury defnition, causes,
Chronic Kidney Disease
Glomerular disease
Acute Kidney Injury (AKI)

What's hot (20)

PPTX
Acute kidney injury
PDF
Hypertension and renal diseases
PPTX
Acute kidney injury
PPTX
Acute kidney injury
PPTX
Acute kidney injury
PPTX
Acute kidney injury
PPTX
tubulointerstitial diseases-
PPTX
Autosomal Dominant Polycystic Kidney Disease
PPTX
Acute Kidney Injury
PPTX
Tubulointerstitial disease
PPTX
PPT
Acute kidney injury
PPTX
AKI 2023.pptx
PPTX
Tubulointerstitial nephritis
PPT
Tubulointerstitial diseases of Kidney
PPTX
ACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
PPTX
Anemia in Chronic Kidney DIsease
PPTX
Focal Segmental Glomerulosclerosis (FSGS)
PPTX
Glomerular diseases
Acute kidney injury
Hypertension and renal diseases
Acute kidney injury
Acute kidney injury
Acute kidney injury
Acute kidney injury
tubulointerstitial diseases-
Autosomal Dominant Polycystic Kidney Disease
Acute Kidney Injury
Tubulointerstitial disease
Acute kidney injury
AKI 2023.pptx
Tubulointerstitial nephritis
Tubulointerstitial diseases of Kidney
ACUTE KIDNEY INJURY / ACUTE RENAL FAILURE
Anemia in Chronic Kidney DIsease
Focal Segmental Glomerulosclerosis (FSGS)
Glomerular diseases
Ad

Viewers also liked (20)

PPT
Acute kidney Injury
PPTX
Approach to a Patient with Acute kidney injury
PDF
Acute Kidney Injury
PPTX
Acute kidney injury (aki)
PPTX
Acute Kidney Injury
PDF
Ci aki for nst 2015
PPTX
Perioperative acute kidney injury case presentation
PDF
Contrast-induced Acute Kidney Injury
PPTX
Recent advancement in managing diabetic nephropathy
PDF
Acute kidney injury prevention new microsoft power po.int presentation
PPTX
Contrast Induced Nephropathy
PPT
PDF
Acute kidney injury(AKI)
PPTX
Diabetic ketoacidosis
PPTX
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
PPT
Contrast induced nephropathy
PDF
Contrast Induced Nephropathy
PPTX
CONTRAST INDUCED NEPHROPATHY
PPTX
Diabetic ketoacidosis: a case study
PPTX
Contrast induced-Acute Kidney Injury
Acute kidney Injury
Approach to a Patient with Acute kidney injury
Acute Kidney Injury
Acute kidney injury (aki)
Acute Kidney Injury
Ci aki for nst 2015
Perioperative acute kidney injury case presentation
Contrast-induced Acute Kidney Injury
Recent advancement in managing diabetic nephropathy
Acute kidney injury prevention new microsoft power po.int presentation
Contrast Induced Nephropathy
Acute kidney injury(AKI)
Diabetic ketoacidosis
CONTRAST INDUCED NEPHROPATHY(CI-AKI)
Contrast induced nephropathy
Contrast Induced Nephropathy
CONTRAST INDUCED NEPHROPATHY
Diabetic ketoacidosis: a case study
Contrast induced-Acute Kidney Injury
Ad

Similar to Acute kidney injury (20)

PPTX
Acute Kidney Injury
PPTX
1 Acute Kidney Injury.pptx
PDF
432813-sEh56-1522281242-Acute-Kidney-Injury (1).pdf
PPTX
Acute Kidney Injury.pptx................
PPTX
Acute renal failure (arf)
PPTX
ACUTE KIDNEY INJURY AND MANAGEMENT
PPTX
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
PPTX
ACUTE RENAL FAILURE.pptx for nursing students
PPTX
Acute kidney injury
PPTX
1 Pharmacotherapy of Renal Disorders ppt.pptx
PPT
ARF final.ppt
PPT
Acute kidney injury in children
PPTX
AKI G2.pptx for the medical student is goods
PPT
Acute renal failure
PPTX
AKI (2).pptx IT IS GOOD FOR THE MEDICAL STUDENTS KNOW ABOUT THE ACUTE KIDNEY...
PPT
AKI Lecture for Postgraduates Students.ppt
PPTX
acute renal failure in icu
DOCX
Acute kidney injury
PPTX
Acute kidney injury
PDF
akifinal-140719124910-phpapp01-1.pdf
Acute Kidney Injury
1 Acute Kidney Injury.pptx
432813-sEh56-1522281242-Acute-Kidney-Injury (1).pdf
Acute Kidney Injury.pptx................
Acute renal failure (arf)
ACUTE KIDNEY INJURY AND MANAGEMENT
Acute kidney Injury today presenting dr. mohamed last 111111 (1).pptx
ACUTE RENAL FAILURE.pptx for nursing students
Acute kidney injury
1 Pharmacotherapy of Renal Disorders ppt.pptx
ARF final.ppt
Acute kidney injury in children
AKI G2.pptx for the medical student is goods
Acute renal failure
AKI (2).pptx IT IS GOOD FOR THE MEDICAL STUDENTS KNOW ABOUT THE ACUTE KIDNEY...
AKI Lecture for Postgraduates Students.ppt
acute renal failure in icu
Acute kidney injury
Acute kidney injury
akifinal-140719124910-phpapp01-1.pdf

Recently uploaded (20)

DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PDF
Transcultural that can help you someday.
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PPTX
Introduction to Medical Microbiology for 400L Medical Students
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
PPTX
09. Diabetes in Pregnancy/ gestational.pptx
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PDF
Plant-Based Antimicrobials: A New Hope for Treating Diarrhea in HIV Patients...
PPTX
Manage HIV exposed child and a child with HIV infection.pptx
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PDF
Copy of OB - Exam #2 Study Guide. pdf
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PEADIATRICS NOTES.docx lecture notes for medical students
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
Transcultural that can help you someday.
OSCE Series Set 1 ( Questions & Answers ).pdf
Introduction to Medical Microbiology for 400L Medical Students
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
09. Diabetes in Pregnancy/ gestational.pptx
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
Plant-Based Antimicrobials: A New Hope for Treating Diarrhea in HIV Patients...
Manage HIV exposed child and a child with HIV infection.pptx
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
focused on the development and application of glycoHILIC, pepHILIC, and comm...
AGE(Acute Gastroenteritis)pdf. Specific.
OSCE Series ( Questions & Answers ) - Set 6.pdf
Electrolyte Disturbance in Paediatric - Nitthi.pptx
Vaccines and immunization including cold chain , Open vial policy.pptx
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
Copy of OB - Exam #2 Study Guide. pdf
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf

Acute kidney injury

  • 2. Anatomy of the Kidney Cardiac OutputApproximately 1,200 ml of blood or 25 % of flows through the kidney in one minute Renal artery and vein Fibrous capsule Corte x Pelvis Pyramid (medulla) Ureter Deep inside the cortex and the medulla regions are long hairpin-like structures called nephrons, these are the functional urine producing unit of the kidney © 2012 – Michel Helmy 2
  • 3. The Nephron The urine producing part of the kidney Distal tubule Collecting duct Loop of Henle Peritubula r capillaries Proximal tubule Bowman’ s capsule Glomerulu s Afferent arteriole (wider) Efferent arteriole(narrow ) There are one million Nephrons in each kidney The efferent arteriole, which is narrower than the afferent arteriole, creating a hydrostatic pressure in glomerulus © 2012 – Michel Helmy 3
  • 4. Renal Function Secretion of three different hormones: SECRETORY FUNCTION EXCRETORY FUNCTION Renin: regulate blood pressure Vitamin D: regulate calcium uptake Excretion product of the kidney: urine EPO: regulate red blood cell production Remove excess fluid Remove waste products Urea & Creatinine Regulate acid/base balance Regulate electrolyte levels © 2012 – Michel Helmy 4
  • 5. Definition: AKI = ARF? AKI = Acute Kidney Injury Intended to describe the entire spectrum of disease from being relatively mild to severe. © 2012 – Michel Helmy 5 ARF = Acute Renal Failure Defined as renal function inadequate to clear the waste products of metabolism despite the absence of correction of hemodynamic or mechanical causes. Clinical manifestations of renal failure include the following: •Uremic symptoms (drowsiness, nausea, hiccough, twitching) •Hyperkalemia •Hyponatremia •Metabolic acidosis Defined as an abrupt change in serum creatinine and/or urine output and classified according the RIFLE criteria
  • 6. Definition of AKI Acute kidney injury (AKI) is defined as any of the following (Not Graded): •Increase in SCr by ≥ 0.3 mg/dl (≥ 26.5 µmol/l) within 48 hours; OR •Increase in SCr to ≥ 1.5 times baseline, which is known or presumed to have occurred within prior 7 days OR •Urine volume <0.5 ml/kg/h for 6 hours © 2012 – Michel Helmy 6
  • 7. Conclusion: AKI is not ARF As you have seen, the terms acute kidney injury (AKI) and acute renal failure (ARF) are not synonymous. While the term renal failure is best reserved for patients who have lost renal function to the point that life can no longer be sustained without intervention, AKI is used to describe the milder as well as severe forms of acute renal dysfunction in patients. Let us have a deeper look at the classification of AKI… © 2012 – Michel Helmy 7
  • 8. Traditional classification of ARF Post-renal ARF Intrinsic-renal ARF The causes of ARF are traditionally divided into three categories. Although this division is useful for classification, all three categories may occur simultaneously in a given patient. ARF is a complication that can occur following any medical condition. It can result from pre-renal causes, intrinsic renal causes or post-renal causes. Acute Renal Failure Pre-renal ARF © 2012 – Michel Helmy 8
  • 9. Pre-renal ARF Kidney hypoperfusion (reduced blood supply) results in both renal ischemia (reduced supply of oxygenated blood) and low GFR By far the most commonly type of ARF seen in ICU Common causes: •intravascular volume depletion dehydration, hemorrhage •decreased cardiac output congestive heart failure, infarct •systemic vasodilatation (dilation of blood vessels) anaphylactic shock, sepsis Acute Renal Failure © 2012 – Michel Helmy 9
  • 10. Intrinsic ARF Possible causes: •miscellaneous renal diseases •toxins Necrosis (is Greek for dead) = death of cell and living tissue Tubule is part of the Nephron, the urine forming part of the kidney Acute Renal Failure Intrinsic renal causes account for 35-40% of ARF cases. The causes of intrinsic renal failure are diseases or toxins causing damage of the small renal vessels and glomeruli, commonly resulting in acute tubular necrosis. © 2012 – Michel Helmy 10
  • 11. Post-renal ARF Increased pressure on the Bowman’s capsule offers a resistance to normal filtration pressure, which causes an acute reduction in GFR Cause: acute obstruction of the flow of urine Acute Renal Failure Post-renal causes account only for about 5% of ARF cases. They are associated with acute obstruction of the flow of urine which can occur at any point in the urinary tract. The obstruction creates a back flow of urine in the kidney which results in an increased pressure on The Bowman’s capsule. The constant pressure offers a resistance to the normal filtration pressure, which causes an acute reduction in GRF. © 2012 – Michel Helmy 11
  • 12. Causes of AKI Volume-responsive AKI © 2012 – Michel Helmy 12 Postoperative AKIHypotension Sepsis-induced AKI Now let’s go back to the concept of AKI! AKI is common in the critically ill, especially in patients with sepsis and other forms of systemic inflammation (e.g. major surgery, trauma, burns), but other causes must be considered. Let us look at the 4 most common causes first:
  • 13. •ADQI (Acute Dialysis Quality Initiative) is a process initiated by a group of physicians from different parts of the world, with the objective to seek consensus and evidence and establish guidelines towards AKI. •They have proposed the RIFLE classification as a definition of AKI. RIFLE defines three grades of severity of ARF on the basis of either an acute increase in serum creatinine, decrease in GFR or decreased urine output. •Risk •Injury •Failure Outcome: •Loss •End-stage renal disease AKI … Stages (RIFLE Criteria) 20
  • 14. Classification of AKI according to RIFLE criteria RIFLE defines three grades of severity of AKI on the basis of either: •acute increase in serum creatinine •decrease in GFR •decreased urine output. Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Gambro Acute Therapies supports the RIFLE definition of AKI © 2012 – Michel Helmy 21
  • 15. 22 Staging of AKI2.1.2: AKI is staged for severity according to the following criteria (below). (Not Graded) Stage Serum Creatinine Urine Output 1 1.5-1.9 times baseline OR ≥0.3 mg/dl (≥ 26.5 µmol/l) increase <0.5 ml/kg/h for 6-12 hours 2 2.0-2.9 times baseline <0.5 ml/kg/h for ≥12 hours 3 3.0 times baseline OR increase in serum creatinine to ≥4.0 mg/dl (≥ 353.6 µmol/l) OR initiation of renal replacement therapy OR, in patients <18 years, decrease in eGFR to <35 ml/min per 1.73 m2 <0.3 ml/kg/h for ≥ 24 hours OR Anuria for ≥ 12 hours
  • 16. RIFLE criteria: Urine Output • Approximately 50-60% of AKI cases are non-oliguric • Patients may continue to make urine despite an inadequate glomerular filtration • Although prognosis is often better if urine output is maintained, use of diuretics to promote urine output does not seem to improve outcome (and some studies even suggests harm) Anuria: <100 ml/24 hour Oliguria: 100-400 ml/24 hour Nonoliguria: >400 ml/24 hour Definition Now when do we talk of ‘Oliguria’? And when is a patient ‘non- oliguric’? © 2012 – Michel Helmy 16
  • 17. Diagnostic work up 1. Urinalysis: Microscopic evaluation of urinary sediment. • Presence of few formed elements or hyaline casts is suggestive of prerenal or postrenal azotemia. • Many RBCs may suggest calculi , trauma , infection or tumor • Eosinophilia : occurs in 95 % of patients with acute allergic nephritis • Brownish pigmented cellular casts and many renal epithelia cells are seen in patients with acute tubular necrosis (ATN )
  • 18. • Pigmented casts without erythrocytes in the sediment from urine but with positive dipstick for occult blood indicates hemoglobinuria or myoglobinuria
  • 19. • Dipstick test: trace or no proteinuria with pre-renal and post-renal AKI; • mild to moderate proteinuria with ATN and moderate to severe proteinuria with glomerular diseases. • RBCs and RBC casts in glomerular diseases • Crystals, RBCs and WBCs in post-renal ARF.
  • 20. 2. Urine and blood Chemistry: • Most of these tests help to differentiate prerenal azotemia, in which tubular reabsorption function is preserved from acute tubular necrosis where tubular reabsorption is severely disturbed. Osmolality or specific gravity: • decreased in ATN and pos-renal AKI (urine is diluted) • while increased in pre-renal AKI ( urine is concentrated)
  • 21. • BUN/plasma creatinine ratio: the BUN/plasma creatinine ratio is • normal at 10-15:1 in ATN, • but may be greater than 20:1 in prerenal disease due to the increase in the passive reabsorption of urea that follows the enhanced proximal transport of sodium and water. • Thus, a high ratio is highly suggestive of prerenal disease as long as some other cause is not present. But this criterion is not highly specific.
  • 22. FE Na • Fractional excretion of Na+: is ratio of urine-to- plasma Na ratio to urine-to-plasma creatinine expressed as a percentage • [ (UNa/PNa)/(Ucr/Pcr )X 100]. • Value below 1% suggest prerenal failure , and values above 1% suggest ATN • Serum K+ and other electrolytes
  • 23. 3. Radiography/imaging • Ultrasonography: helps to see the presence of two kidneys, for evaluating kidney size and shape, and for detecting hydronephrosis or hydroureter. • It also helps to see renal calculi, and renal vein thrombosis. • Retrograde pyelography: is done when obstructive uropathy is suspected
  • 24. Management of AKI 1. Prevention: • Because there are no specific therapies for ischemic or nephrotoxic AKI, Many cases of ischemic AKI can be avoided by close attention to cardiovascular function and intravascularintravascular volume in high-risk patientsvolume in high-risk patients, such as the elderly and those with preexisting renal insufficiency.
  • 25. • Aggressive restoration of intravascular volume has been shown to reduce the incidence of ischemic AKI dramatically after major surgery or trauma, burns, or cholera prevention is of paramount importance.
  • 26. • The incidence of nephrotoxic ARF can be reduced by tailoring the dosage of potential nephrotoxins to body size and GFR; for example, reducing the dose or frequency of administration of drugs in patients with preexisting renal impairment
  • 27. • Maintenance of urine output: Loop diuretics may be usefully to convert the oliguric form of ATN to the nonoliguric form. • High doses of loop diuretics such as Furosemide (up to 200 to 400 mg intravenously) may promote diuresis in patients who fail to respond to conventional doses
  • 28. Look for cause and treat • Specific Therapies: • To date, there are no specific therapies for established intrinsic renal ARF due to ischemia or nephrotoxicity. • Management of these disorders should focus on elimination of the causative hemodynamic abnormality or toxin, avoidance of additional insults, and prevention and treatment of complications. • Specific treatment of other causes of intrinsic renal ARF depends on the underlying pathology.
  • 29. Prerenal ARF: • The composition of replacement fluids for treatment of prerenal ARF due to hypovolemia must be tailored according to the composition of the lost fluid. • Severe hypovolemia due to hemorrhage should be corrected with packed red blood cells, whereas isotonic saline is usually appropriate replacement for mild to moderate hemorrhage or plasma loss (e.g., burns, pancreatitis).
  • 30. • Urinary and gastrointestinal fluids can vary greatly in composition but are usually hypotonic. • Hypotonic solutions (e.g., 0.45% saline) are usually recommended as initial replacement in patients with prerenal ARF due to increased urinary or gastrointestinal fluid losses, although isotonic saline may be more appropriate in severe cases
  • 31. • Subsequent therapy should be based on measurements of the volume and ionic content of excreted or drained fluids. Serum potassium and acid-base status should be monitored carefully.
  • 32. Postrenal ARF: • Management of postrenal ARF requires close collaboration between nephrologist, urologist, and radiologist. • Obstruction of the urethra or bladder neck is usually managed initially by transurethral or suprapubic placement of a bladder catheter, which provides temporary relief while the obstructing lesion, is identified and treated definitively. Similarly, ureteric obstruction may be treated initially by percutaneous catheterization of the dilated renal pelvis or ureter.
  • 33. 4. Supportive Measures: (Conservative therapy ) • Dietary management: • Generally, sufficient calorie reflects a diet that provides 40-60 gm of protein and 35-50 kcal/kg lean body weight. • In some patients, severe catabolism occurs and protein supplementation to achieve 1.25 gm of protein /kg body weight is required to maintain nitrogen balance. • Restricting dietary protein to approximately 0.6 g/kg per day of protein of high biologic value (i.e., rich in essential amino acids) may be recommended in sever azotemia.
  • 34. Fluid and electrolyte management : • Following correction of hypovolemia, • Total oral and intravenous fluid administration should be equal to daily sensible losses (via urine, stool, and NG tune o surgical drainage ) plus estimated insensible ( i.e. , respiratory and derma ) losses which usually equals 400 – 500 ml/day. • Strict input output monitoring is important.
  • 35. • Hypervolemia: can usually be managed by restriction of salt and water intake and diuretics. • Metabolic acidosis: is not treated unless serum bicarbonate concentration falls below 15 mmol/L or arterial pH falls below 7.2. • More severe acidosis is corrected by oral or intravenous sodium bicarbonate.
  • 36. • Initial rates of replacement are guided by estimates of bicarbonate deficit and adjusted thereafter according to serum levels. • Patients are monitored for complications of bicarbonate administration such as hypervolemia, metabolic alkalosis, hypocalcemia, and hypokalemia. • From a practical point of view, most patients requiring sodium bicarbonate need emergency dialysis within days.
  • 37. Hyperkalemia: cardiac and neurologic complications may occur if serum K+ level is > 6.5 mEq/L • o Restrict dietary K+ intake • o Give calcium gluconate 10 ml of 10% solution over 5 minutes • o Glucose solution 50 ml of 50 % glucose plus Insulin 10 units IV • o Give potassium –binding ion exchange resin • o Dialysis: it medial therapy fails or the patient is very
  • 38. • Hyperphosphatemia is usually controlled by restriction of dietary phosphate and by oral aluminum hydroxide or calcium carbonate, which reduce gastrointestinal absorption of phosphate. • Hypocalcemia does not usually require treatment.
  • 39. • Anemia: may necessitate blood transfusion if severe or if recovery is delayed. • GI bleeding: Regular doses of antacids appear to reduce the incidence of gastrointestinal hemorrhage significantly and may be more effective in this regard than H2 antagonists, or proton pump inhibitors. • Meticulous care of intravenous cannulae, bladder catheters, and other invasive devices is mandatory to avoid infections
  • 40. Dialysis • Indications and Modalities of Dialysis: - Dialysis replaces renal function until regeneration and repair restore renal function. Hemodialysis and peritoneal dialysis appear equally effective for management of ARF. Absolute indications for dialysis include: • 􀂾 Symptoms or signs of the uremic syndrome • 􀂾 Refractory hypervolemia • 􀂾 Sever hyperkalemia • 􀂾 Metabolic acidosis.
  • 41. • Patients with no complicating factors who survive an episode of acute renal failure have a 90 % chance of complete recovery of kidney function.
  • 42. RECOVERY Complete Renal Recovery is defined when: Serum Creatinine (SCrt) is not more than 50% increased from baseline example: if baseline SCrt is 1 mg/dL (88 mmol/L) complete recovery is said to occur if the new steady state SCrt is <1.5 mg/dL (133 mmol/L) Partial Renal Recovery is defined when: The above condition for complete recovery is not met but the patient does not require chronic dialysis (i.e. renal ‘loss’ has not occurred)